Jun
2026
Shanghai New International Expo Center
Visit us
stand E1.1C07, Pharma Excipients
Zone

CURAPATH

Exhibitor at CPHI & PMEC China 2026
About Us

Curapath is a European Contract Development and Manufacturing Organization (CDMO) specialized in polymer- and lipid-based non-viral drug delivery systems and their components. This includes the development and manufacturing of polymer and lipid excipients, lipid nanoparticles (LNPs), polymer nanoparticles (PNPs), and advanced drug conjugation strategies. We support regulated biotech, pharmaceutical, and medical device programs from early development through GMP and commercial manufacturing.

Read more Show less
Products
Show more Show less
Sales Markets
Show more Show less
Categories
more categories Show less
  • Country/Region:
    Spain
  • On CPHI since:
    2023
  • Certificates:
    1
  • Employees:
    50 - 99
Company types
CMO/CDMO
Primary activities
Analytical Services
Chemical Development
Custom Manufacturing/Custom Synthesis
Excipients Manufacturer
View company profile
Contact info
Show contact info Hide contact info
Event information
CPHI & PMEC China 2026
  • 16 Jun 2026 - 18 Jun 2026
  • Shanghai New International Expo Center
  • Visit us at stand E1.1C07, Pharma Excipients

Products Featured at CPHI & PMEC China 2026

  • Bioconjugation

    Product Bioconjugation

    Polymer bioconjugation offers powerful strategies to extend half-life, improve stability, and enable encapsulation of therapeutic molecules. By conjugating polymers to proteins, peptides, or other actives, it is possible to enhance pharmacokinetics, reduce immunogenicity, and unlock new delivery pathways. ...
  • Custom polymers and lipids

    Product Custom polymers and lipids

    Custom polymers and lipids enable the creation of tailored delivery systems that meet the unique requirements of each therapeutic program. At Curapath, we support our partners with bespoke synthesis and design, offering flexibility in polymer architecture, lipid structures, functionalization, and scale. Th...
  • ionizable lipids

    Product ionizable lipids

    Ionizable lipids are key components in LNP formulations, enabling efficient RNA encapsulation and protection, while ensuring intracellular release through their pH-dependent charge switch. This unique property makes them essential for the safe and effective delivery of nucleic acid-based therapeutics. At ...
  • Ready-to-use formulations

    Product Ready-to-use formulations

    Ready-to-use formulations simplify development by providing immediate access to well-characterized LNP systems. At Curapath, we offer a spectrum ranging from standard reference formulations to custom-designed systems, where we combine our proprietary shielding lipids with innovative ionizable lipids. This ...
  • Shielding lipids

    Product Shielding lipids

    Shielding lipids play a crucial role in prolonging circulation time and enhancing the stability of LNPs by preventing opsonization and rapid clearance. Traditionally, PEG-lipids have been used for this purpose, but concerns around immunogenicity and tolerability have driven the search for better solutions....

Curapath Resources (1)

  • Product Catalog

    Brochure Product Catalog

    Discover Curapath's cutting-edge offerings in our catalog. Explore our LNP and PNP components, as well as our polymer conjugates, all designed to advance drug delivery. Enhance your research and development with our high-quality products.Advanced Polymer & Lipid Solutions for Non-Viral Drug DeliveryPEG-free excipients, transfection reagents, and polymer platforms for next-generation therapeutics